CI Sprint
A focused assignment to resolve a specific intelligence gap, assess a competitor move or prepare for an upcoming milestone.
Focused question → Targeted research → Clear answer Pharma & Biotech Intelligence
Intelligence that informs
better decisions
Specialist research and analysis across clinical, commercial, regulatory and portfolio domains to help pharma and biotech teams make sharper, more confident choices.
Competitive IntelligenceMarket StrategyClinical DevelopmentCommercialisation
Trusted intelligence across
the product lifecycle
the product lifecycle
ClinicalDevelopment intelligence
CommercialMarket intelligence
RegulatoryPathway intelligence
PortfolioAsset & strategy insight
The Strategic Questions We Help Answer
Clarity on the questions
that matter most.
Research is organised around the decisions teams are preparing to make.
01
How is the competitive and evidence landscape evolving?
02
What are the real commercial and access opportunities?
03
How should we position and differentiate the asset?
04
Where should we prioritise investment across the portfolio?
05
What external signals should inform our next decision?
Our Approach
A structured, evidence-led
intelligence process.
A consulting-grade approach that combines targeted research, primary insight and critical analysis to deliver clear, decision-ready answers.
How We Work →01FrameDefine the decision and KIQs
→
02DiscoverGather relevant evidence
→
03AnalyseTest and interpret findings
→
04AdviseTranslate insight into action
KIQ-ledResearch design shaped around the decision
Multi-sourceSecondary research and expert perspectives
Decision-focusedClear implications for strategy and action
Flexible partnerFocused support for pharma, biotech and CI teams
Our Capabilities
End-to-end intelligence
across the asset lifecycle.
Focused expertise across the clinical, commercial, regulatory and portfolio questions that influence asset development and market direction.
View all capabilities →
01 / DEVELOPMENT
Clinical Intelligence →
Trial design, development strategy, enrollment, endpoints, readout expectations and evidence positioning.
02 / MARKET
Commercial Intelligence →
Market dynamics, customer priorities, positioning, launch preparedness and competitive response.
03 / REGULATORY
Regulatory Intelligence →
Filing strategy, pathways, milestones, approval outlook and label developments.
04 / PORTFOLIO
Portfolio Intelligence →
Asset prioritisation, lifecycle opportunities, portfolio fit and strategic scenarios.
ALSO AVAILABLE Primary Research · Congress Intelligence · Ongoing Monitoring · Rapid Intelligence Support
Engagement Models
Support shaped around
the question and timeline.
From a single intelligence gap to a sustained monitoring programme, the engagement is scoped around the evidence required and the decision date.
Competitive Deep Dive
A broader assessment combining secondary research, expert interviews and cross-functional analysis across an asset or market.
Research design → Evidence integration → Strategic assessmentOngoing CI
A defined monitoring rhythm tracking competitor, clinical, regulatory and commercial developments and their implications.
Monitor → Interpret change → Keep teams informed Selected Work
Real-world intelligence.
Practical strategic value.
Anonymised examples of how targeted research and analysis have supported clinical, commercial and portfolio decisions. Company and product identifiers are intentionally withheld.
View Selected Work →CASE STUDY / PORTFOLIO STRATEGY
Meningococcal Vaccine Portfolio Strategy
Assessment of competitor development, regulatory direction and commercial positioning to understand portfolio implications and strategic choices.
Explore case overview ↗ Start a Conversation
What decision are you
working towards?
Share the asset, market or intelligence question in focus. Grapon can help shape a focused research approach around the evidence your team needs.